4188:TSEMitsubishi Chemical Group Corporation Analysis
Data as of 2026-06-11 - not real-time
¥1,036.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Mitsubishi Chemical Group trades at ¥1,036, comfortably above the 20‑day SMA (¥1,060.8) but still below the 50‑day SMA (¥992.9) and 200‑day SMA (¥937), signalling a short‑term bullish bias within a longer‑term uptrend. Technical indicators are mixed: RSI sits at a neutral 49.8, while the MACD histogram is negative (‑11.3) and the signal line is bearish, suggesting possible near‑term downside pressure. Fundamentally, revenue fell 10% YoY, operating margin is –8.4% and trailing EPS is negative (‑¥60.46), yet forward EPS is projected positive (¥91.18) with a forward P/E of 11.36, indicating an expected earnings rebound. The stock offers a 3.14% dividend yield, but a payout ratio of 123% raises concerns about sustainability. Balance‑sheet metrics show ample cash (¥621B) offset by high debt (¥1,890B) and a debt‑to‑equity of 78, highlighting leverage risk. Recent earnings‑call commentary noted a 2% dip in core operating income and a 79% plunge in operating income due to non‑recurring items, underscoring earnings volatility. The market sentiment is extremely greedy (Fear‑Greed Index 83.4) and the price sits near the support level of ¥985.9, with resistance at ¥1,163, while volatility remains elevated at ~45% over 30 days.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD signal and decreasing volume
- Recent earnings pressure and negative trailing EPS
- Proximity to support level at ¥985.9
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward EPS outlook and modest forward P/E of 11.36
- Undervalued price relative to DCF fair value (+12% upside)
- Low beta (0.49) indicating limited market volatility
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Cheap price‑to‑book (0.80) and potential balance‑sheet deleveraging
- Expected earnings recovery reflected in forward EPS
- Attractive dividend yield if payout ratio improves
Key Metrics & Analysis
Financial Health
Revenue Growth-10.10%
Profit Margin0.32%
P/E Ratio11.4
ROE-0.70%
ROA0.34%
Debt/Equity78.29
P/B Ratio0.8
Op. Cash Flow¥436.3B
Free Cash Flow¥112.5B
Technical Analysis
TrendBullish
RSI49.8
Support¥985.90
Resistance¥1,163.00
MA 20¥1,060.80
MA 50¥992.86
MA 200¥936.98
MACDBearish
VolumeDecreasing
Fear & Greed Index83.38
Valuation
Fair Value¥149.95
Target Price¥1,037.27
Upside/Downside0.12%
GradeUndervalued
TypeValue
Dividend Yield3.14%
Risk Assessment
Beta0.49
Volatility44.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.